Skip to content

The Effects of PaCO2 Levels on Cerebral Metabolism and Perfusion During Induced Hypothermia.

The Effects of PaCO2 Levels on Cerebral Metabolism and Perfusion During Induced Hypothermia.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00766103
Enrollment
8
Registered
2008-10-03
Start date
2006-12-31
Completion date
2008-05-31
Last updated
2016-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Metabolism and Perfusion

Keywords

Cerebral metabolism, perfusion, induced hypothermia

Brief summary

Incidence of hypo- and hypercarbia during induced hypothermia after cardiac arrest is high. The original report from HACA-group reported that hypothermia treated patients had improved survival and neurological outcome. Suprisingly, in that trial normocarbia was not achieved even though the aim was set for ventilatory support as normoventilation. This study aims to investigate the effects of mild hypo- and hypercarbia on cerebral perfusion (blood flow, intracranial pressure) and metabolism (microdialysate metabolites). We hypothesize that uncontrolled ventilatory suppport may render the patients in risk of exacerbation of neuronal damage, conversely, further improvement in outcome may be achieved with succesfull ventilatory management. We intend to enroll 10 out-of-hospital cardiac arrest patients succesfully resuscitated and subsequently treated with controlled hypothermia for 24 hours. The patients in need of anticoagulation are excluded. We plan to induce mild hypocarbia and hypercarbia during and after induced hypothermia. Metabolic and perfusion data are collected with clinically used methods such as transcranial doppler, intracranial pressure measurement, near infrared spectroscopy, jugular bulb, intracerebral microdialysis).

Interventions

OTHERmild hypo- and hyperventilation

induction of mild hypo- and hypercarbia

Sponsors

Tampere University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

succesfull resuscitation of out of hospital cardiac arrest, primary rhytm shockable

Exclusion criteria

* known coagulopathy, need of anticoagulation therapy, need of interventional cardiological procedures

Design outcomes

Primary

MeasureTime frame
surrogate physiological endpoints60minutes

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026